An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission.
about
Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeuticsA final common pathway for depression? Progress toward a general conceptual framework.Antidepressive effect of mirtazapine in post-myocardial infarction depression is associated with soluble TNF-R1 increase: data from the MIND-IT.Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression.Chronic constriction injury-induced nociception is relieved by nanomedicine-mediated decrease of rat hippocampal tumor necrosis factorAntinociception mediated by alpha(2)-adrenergic activation involves increasing tumor necrosis factor alpha (TNFalpha) expression and restoring TNFalpha and alpha(2)-adrenergic inhibition of norepinephrine releaseAnti-inflammatory properties of desipramine and fluoxetine.Increasing TNF levels solely in the rat hippocampus produces persistent pain-like symptomsAnticytokine therapy in neuropathic pain management.Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder.A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder.Acute desipramine restores presynaptic cortical defects in murine experimental autoimmune encephalomyelitis by suppressing central CCL5 overproduction.The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications.Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseasesCCL5-Glutamate Cross-Talk in Astrocyte-Neuron Communication in Multiple Sclerosis.The effect of TNF-alpha blockers on psychometric measures in ankylosing spondylitis patients: a preliminary observation.Antidepressant drug, desipramine, alleviates allergic rhinitis by regulating Treg and Th17 cells.
P2860
Q24685475-BDCBAAB2-6E4A-47F7-A7EB-6793A149A3A7Q30491982-CB549973-8BC7-4DB9-9AF9-BCFB8D9AF514Q33791816-A1F7B4E4-CAC8-4D5A-AF90-D2223147FD58Q35237104-0AE6B421-2A74-4ACA-9049-9C97207D5C5BQ35597102-556C137F-DF4C-44F9-BB3D-76176CB45C98Q35728532-EE9FE014-14B0-42F1-ACD0-5FCB95617FD0Q35807992-1B7F9946-E6C5-49F4-AD3F-FBD8FFCDDE95Q36160364-DBCBA9DB-882B-495C-A7A6-24D055BA8DEFQ36998861-5E17ED9F-6C85-4ECA-8158-0F5225FD0B91Q37032660-46BC35F2-8A55-45AF-B23F-4BB6EA626F2BQ37395509-96F4B310-0832-4C16-9330-39B245CB0B0EQ37719431-120FC09C-2CD5-4703-9838-AD9CB13B070CQ38004705-B53C9EFE-79AF-46D4-A773-17C01F10B5B8Q38371329-32DD1D06-8AD3-460A-8C12-36FBC13D24AEQ41471364-ED02CD5C-7604-4C3C-B1F6-E78EB79051B8Q44382485-11CD548F-6BE6-4CF7-A072-9B21D4419227Q44950102-AB01AC8B-0B16-460D-9A77-E505CD5782AE
P2860
An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
An antidepressant mechanism of ...... radrenergic neurotransmission.
@en
An antidepressant mechanism of ...... radrenergic neurotransmission.
@nl
type
label
An antidepressant mechanism of ...... radrenergic neurotransmission.
@en
An antidepressant mechanism of ...... radrenergic neurotransmission.
@nl
prefLabel
An antidepressant mechanism of ...... radrenergic neurotransmission.
@en
An antidepressant mechanism of ...... radrenergic neurotransmission.
@nl
P2093
P1433
P1476
An antidepressant mechanism of ...... radrenergic neurotransmission.
@en
P2093
Ignatowski TA
Reynolds JL
Spengler RN
P304
P356
10.1016/J.NEUROSCIENCE.2005.02.023
P407
P577
2005-01-01T00:00:00Z